Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	entity_10	entity_11	entity_12	entity_13	json	split
SREBP activation decreased as ECs migration slowed; ( 2) Coincidental with SREBP activation, mRNA expression of its target genes such as low density lipoprotein receptor, HMG - CoA reductase, and fatty acid synthase also increased in migrating ECs population as detected by real - time PCR; ( 3) Migration induced SREBP activation in ECs was inhibited by SREBP - acting protein RNAi and pharmacologically by 25 - hydroxycholesterol; ( 4) Inhibition of SREBP led to decreased ECs migration in various models; ( 5) Cells genetically deficient in SREBP - acting protein, S1P, or S2P, phenotypically exhibited impaired migration; ( 6) SREBP inhibition in ECs suppressed the activity of small GTPase Cdc42, a key molecule for ECs motility.	SREBP,0,5,Gene_or_gene_product	SREBP,75,80,Gene_or_gene_product	low density lipoprotein receptor,137,169,Gene_or_gene_product	HMG - CoA reductase,171,190,Gene_or_gene_product	fatty acid synthase,196,215,Gene_or_gene_product	SREBP,314,319,Gene_or_gene_product	SREBP - acting protein,355,377,Gene_or_gene_product	SREBP,452,457,Gene_or_gene_product	SREBP - acting protein,544,566,Gene_or_gene_product	S1P,568,571,Gene_or_gene_product	S2P,576,579,Gene_or_gene_product	SREBP,631,636,Gene_or_gene_product	Cdc42,695,700,Gene_or_gene_product	"[{""token"": ""SREBP"", ""start_span"": 0, ""end_span"": 5, ""type"": ""Gene_or_gene_product""}, {""token"": ""SREBP"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""low density lipoprotein receptor"", ""start_span"": 137, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMG - CoA reductase"", ""start_span"": 171, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}, {""token"": ""fatty acid synthase"", ""start_span"": 196, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}, {""token"": ""SREBP"", ""start_span"": 314, ""end_span"": 319, ""type"": ""Gene_or_gene_product""}, {""token"": ""SREBP - acting protein"", ""start_span"": 355, ""end_span"": 377, ""type"": ""Gene_or_gene_product""}, {""token"": ""SREBP"", ""start_span"": 452, ""end_span"": 457, ""type"": ""Gene_or_gene_product""}, {""token"": ""SREBP - acting protein"", ""start_span"": 544, ""end_span"": 566, ""type"": ""Gene_or_gene_product""}, {""token"": ""S1P"", ""start_span"": 568, ""end_span"": 571, ""type"": ""Gene_or_gene_product""}, {""token"": ""S2P"", ""start_span"": 576, ""end_span"": 579, ""type"": ""Gene_or_gene_product""}, {""token"": ""SREBP"", ""start_span"": 631, ""end_span"": 636, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cdc42"", ""start_span"": 695, ""end_span"": 700, ""type"": ""Gene_or_gene_product""}]"	train
Treatment with pharmacological inhibitors and small interfering RNAs reveal that induction and activation of Sp1, HIF1alpha, and Stat3 facilitate their nuclear localization and binding to their specific motifs of the VEGF promoter and induce VEGF expression via two independent pathways, DCN / EGFR / phosphoinositide - 3 kinase / AKT and DCN / EGFR / ERK1 / 2, respectively, in DCN synthesizing MCE cells.	Sp1,109,112,Gene_or_gene_product	HIF1alpha,114,123,Gene_or_gene_product	Stat3,129,134,Gene_or_gene_product	VEGF,217,221,Gene_or_gene_product	VEGF,242,246,Gene_or_gene_product	DCN,288,291,Gene_or_gene_product	EGFR,294,298,Gene_or_gene_product	phosphoinositide - 3 kinase,301,328,Gene_or_gene_product	AKT,331,334,Gene_or_gene_product	DCN,339,342,Gene_or_gene_product	EGFR,345,349,Gene_or_gene_product	ERK1 / 2,352,360,Gene_or_gene_product	DCN,379,382,Gene_or_gene_product	"[{""token"": ""Sp1"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF1alpha"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""Stat3"", ""start_span"": 129, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 217, ""end_span"": 221, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 242, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCN"", ""start_span"": 288, ""end_span"": 291, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 294, ""end_span"": 298, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphoinositide - 3 kinase"", ""start_span"": 301, ""end_span"": 328, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT"", ""start_span"": 331, ""end_span"": 334, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCN"", ""start_span"": 339, ""end_span"": 342, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGFR"", ""start_span"": 345, ""end_span"": 349, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK1 / 2"", ""start_span"": 352, ""end_span"": 360, ""type"": ""Gene_or_gene_product""}, {""token"": ""DCN"", ""start_span"": 379, ""end_span"": 382, ""type"": ""Gene_or_gene_product""}]"	valid
Ba / F3 cells transformed to growth factor independence by various oncogenic PTKs ( TEL / JAK2, TEL / TRKC, TEL / ABL, BCR / ABL, FLT3 - ITD, and H4 / PDGFbetaR) show abundant expression of PIM - 1 and PIM - 2.	TEL,84,87,Gene_or_gene_product	JAK2,90,94,Gene_or_gene_product	TEL,96,99,Gene_or_gene_product	TRKC,102,106,Gene_or_gene_product	TEL,108,111,Gene_or_gene_product	ABL,114,117,Gene_or_gene_product	BCR,119,122,Gene_or_gene_product	ABL,125,128,Gene_or_gene_product	FLT3 - ITD,130,140,Gene_or_gene_product	H4,146,148,Gene_or_gene_product	PDGFbetaR,151,160,Gene_or_gene_product	PIM - 1,190,197,Gene_or_gene_product	PIM - 2,202,209,Gene_or_gene_product	"[{""token"": ""TEL"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""JAK2"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEL"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Gene_or_gene_product""}, {""token"": ""TRKC"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Gene_or_gene_product""}, {""token"": ""TEL"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""BCR"", ""start_span"": 119, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""ABL"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""FLT3 - ITD"", ""start_span"": 130, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""H4"", ""start_span"": 146, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""PDGFbetaR"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 1"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""PIM - 2"", ""start_span"": 202, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"	test
